Instinct Science Company Profile

Background

Instinct Science, founded in 2017 and headquartered in Doylestown, Pennsylvania, is a leading provider of veterinary software solutions. The company's mission is to enhance patient care and improve staff efficiency in veterinary practices through thoughtfully designed technology. Instinct's products are integral to numerous university teaching hospitals, internship and residency training centers, and advanced multi-specialty/emergency care practices worldwide.

Key Strategic Focus

Instinct Science focuses on developing innovative software systems tailored for emergency and specialty veterinary centers. Their flagship products include:

Instinct EMR: A cloud-based electronic medical records system featuring natively integrated digital treatment sheets, enabling centralized patient history tracking and care management.

Instinct Treatment Plan: A workflow tool designed to streamline patient care processes.

Plumb’s Veterinary Drugs: A trusted point-of-care resource providing comprehensive drug information.

Clinician’s Brief: An educational resource offering practical information to support clinicians.

These products aim to boost team efficiency, enhance patient care, and improve revenue capture in veterinary practices.

Financials and Funding

In November 2022, Instinct Science secured a significant growth equity investment from Mainsail Partners, a growth equity firm specializing in fast-growing software companies. The investment is intended to accelerate product development and enhance services and support for veterinary hospitals. As of 2023, the company reported revenue of $8.2 million, reflecting consistent growth since its inception.

Technological Platform and Innovation

Instinct Science distinguishes itself through its proprietary technologies and innovative approaches:

Integrated Digital Treatment Sheets: A first in the veterinary space, allowing seamless tracking of patient history and care management.

Cloud-Based Solutions: Ensuring accessibility and scalability for veterinary practices of all sizes.

Point-of-Care Resources: Integration with Plumb’s Veterinary Drugs and Clinician’s Brief provides real-time, reliable information to veterinary professionals.

These innovations position Instinct Science as a forward-thinking provider in the veterinary software industry.

Leadership Team

Dr. Caleb Frankel: Founder and CEO. A practicing emergency veterinarian, Dr. Frankel leads the company's strategic vision and product development.

Elizabeth Green: President of VetMedux, a division of Instinct Science. Founder of VetMedux, she brings extensive experience in veterinary education and point-of-care information.

Their combined expertise drives the company's mission to revolutionize veterinary practice management through technology.

Leadership Changes

In January 2024, following the acquisition of VetMedux, Elizabeth Green joined Instinct's management team as President of VetMedux. This strategic addition enhances the company's leadership and aligns with its mission to better serve veterinary professionals.

Competitor Profile

Market Insights and Dynamics

The veterinary software market is projected to reach approximately $438 million by 2025, with major players commanding around 60% of the market share. This growth is driven by increasing pet ownership and the demand for efficient veterinary practice management solutions.

Competitor Analysis

Instinct Science operates in a competitive landscape with several key players:

Covetrus: A global animal-health technology and services company offering a comprehensive suite of products for veterinary practices.

IDEXX Laboratories: Provides a range of diagnostic and information technology-based products and services for veterinary practices.

ezyVet: Offers cloud-based practice management software designed for veterinary practices.

These competitors have established market presence and extensive product offerings, posing challenges for newer entrants like Instinct Science.

Strategic Collaborations and Partnerships

In January 2024, Instinct Science acquired VetMedux, the owner of Clinician's Brief and Plumb’s Veterinary Drugs. This acquisition combines technology and clinical content expertise, enhancing Instinct's product portfolio and providing veterinary professionals with integrated tools for patient care.

Operational Insights

Instinct Science's strategic focus on integrating clinical content with practice management software differentiates it from competitors. The company's commitment to innovation and user-friendly design has led to rapid adoption among advanced veterinary care centers. However, as a relatively new player, building brand recognition and expanding market share remain critical challenges.